Linghua Zhu

Prof. Linghua Zhu


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2022 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
JWJun Wang
Jun Wang
BWBeidi Wang
Beidi Wang
BZBiting Zhou
Biting Zhou
JCJing Chen
Jing Chen
JQJia Qi
Jia Qi
JCJian Chen
Jian Chen
Background: Gastric cancer (GC), the most commonly diagnosed cancer worldwide with poor 5-year survival rate in advanced stages. Although immune-related and survival-related biomarkers, which typically comprise aberrantly expressed long non-coding RNAs (lncRNAs) and genes, have been identified, there are no reports of immune-related lncRNA pair (IRLP) signatures for GC. Methods: In this study, we acquired lncRNA expression profiles from The Cancer Genome Atlas (TCGA) and used the least absolute shrinkage and selection operator (LASSO) Cox proportional hazards model (iteration = 1000) to develop a IRLP prognostic signature. The area under curve (AUC) was used to assess the prognosis predictive power. The multivariate Cox regression analysis was performed to identify whether this signature was an independent prognostic factor. The immune cell infiltration analysis was performed between the two risk groups. Last, molecular experiments were performed to explore LINC01082 is involved in the development of GC. Results: We acquired lncRNA expression profiles and used the LASSO Cox model to develop an 18-IRLP signature with a strong prognostic predictive power. The 5-year AUC values of the training, validation, and overall TCGA datasets were 0.77, 0.86, and 0.80, respectively. The different prognostic outcomes between the high- and low-risk groups were determined using our 18-IRLP signature. Moreover, our 18-IRLP signature was an independent prognostic factor as per the multivariate Cox regression analysis, and showed better prognostic evaluation than the traditional TNM staging system as well as other clinical features. We also found differences in cancer-associated fibroblast and macrophage M2 infiltration and the expression of PD-L1, CTLA4, LAG3, and HLA were also observed between the two risk groups (P < 0.05). Analysis of biological functions revealed that target genes of the lncRNAs in the IRLP signature were enriched in focal adhesion and regulation of actin cytoskeleton. Finally, as one of significant candidates of IRLP signature, overexpression of LINC01082 suppressed the invasion ability of GC cells as well as PD-L1 expression profiles. Conclusions: Our novel 18-IRLP signature provides new insights regarding immunological biomarkers, imparts a better understanding of the tumor immune microenvironment, and can be used for predicting prognosis and evaluating immune response in GC.

3 June 2022 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
WYWeihua Yu
Weihua Yu
GCGuojun Chen
Guojun Chen
JYJiafei Yan
Jiafei Yan
XWXianfa Wang
Xianfa Wang
YZYiping Zhu
Yiping Zhu
LZLinghua Zhu
Linghua Zhu
Gastric cancer is a common type of gastrointestinal malignant tumor in China. The mechanism of the development and progression of gastric cancer remains the continuing research focus. The tumor microenvironment plays an important role in the development and progression of tumors. The present study used single-cell sequencing data to characterize the microenvironment of gastric cancer, investigate the effects of oxidative stress on gastric cancer microenvironmental cells through the comparison between cancer tissue and normal tissue, and identify the key genes associated with gastric cancer patients’ survival. The results showed that compared with normal gastric tissue, gastric cancer tissue had a decreased oxidative stress response, weaker oxidative detoxification ability, and increased oxidative stress-induced cell death. In the different types of single cells of gastric cancer microenvironment, the oxidative stress response of T cell was increased, the ability of oxidative detoxification was enhanced, and the oxidative stress-induced cell death was exacerbate. Mucous cell showed the same trend as gastric cancer cells: decreased oxidative stress response, weak oxidative detoxification ability, and weakened oxidative stress-induced cell death. Moreover, TRIM62, MET, and HBA1, which were significantly associated with oxidative stress, may be biomarkers for the prognosis of gastric cancer. High expression of TRIM62 indicated a good prognosis, while MET and HBA1 indicated a poor prognosis, which will be confirmed by further clinical studies.

16 October 2023 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PLPeng Luo
Peng Luo
GCGuojun Chen
Guojun Chen
ZSZhaoqi Shi
Zhaoqi Shi
JYJin Yang
Jin Yang
XWXianfa Wang
Xianfa Wang
LZLinghua Zhu
Linghua Zhu
Introduction: The 5-year survival of gastric cancer (GC) patients with advanced stage remains poor. Some evidence has indicated that tryptophan metabolism may induce cancer progression through immunosuppressive responses and promote the malignancy of cancer cells. The role of tryptophan and its metabolism should be explored for an in-depth understanding of molecular mechanisms during GC development.Material and methods: We utilized the Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) dataset to screen tryptophan metabolism-associated genes via single sample gene set enrichment analysis (ssGSEA) and correlation analysis. Consensus clustering analysis was employed to construct different molecular subtypes. Most common differentially expressed genes (DEGs) were determined from the molecular subtypes. Univariate cox analysis as well as lasso were performed to establish a tryptophan metabolism-associated gene signature. Gene Set Enrichment Analysis (GSEA) was utilized to evaluate signaling pathways. ESTIMATE, ssGSEA, and TIDE were used for the evaluation of the gastric tumor microenvironment.Results: Two tryptophan metabolism-associated gene molecular subtypes were constructed. Compared to the C2 subtype, the C1 subtype showed better prognosis with increased CD4 positive memory T cells as well as activated dendritic cells (DCs) infiltration and suppressed M2-phenotype macrophages inside the tumor microenvironment. The immune checkpoint was downregulated in the C1 subtype. A total of eight key genes, EFNA3, GPX3, RGS2, CXCR4, SGCE, ADH4, CST2, and GPC3, were screened for the establishment of a prognostic risk model.Conclusion: This study concluded that the tryptophan metabolism-associated genes can be applied in GC prognostic prediction. The risk model established in the current study was highly accurate in GC survival prediction.

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
GCGuojun Chen
Guojun Chen
YZYiping Zhu
Yiping Zhu
XLXiao Liang
Xiao Liang
XWXianfa Wang
Xianfa Wang
WYWeihua Yu
Weihua Yu
RMRui Ma
Rui Ma
This study aimed to investigate the effect of bile duct‐targeting lecithins‐ (PC‐) coupled decorin (DCN) (PC‐DCN) nanoliposomes against liver fibrosis in vitro and in vivo. We prepared PC‐DCN nanoliposomes by using rat astrocytes, HSC‐T6, to verify the antifibrosis effect of PC‐DCN in vitro. First, we established a rat model of carbon tetrachloride‐induced fibrosis. PC‐DCN nanoliposomes were then injected into fibrotic rats via the portal vein or bile duct. The EdU assay was performed to analyze cell proliferation. Immunofluorescence staining was used to detect α‐smooth muscle actin (α‐SMA) expression. Western blot was performed to examine the expression of α‐SMA, collagen type I alpha 1 (COL1A1), and transforming growth factor‐β (TGF‐β) protein. The levels of aspartate transaminase (AST), alanine transaminase (ALT), and total bilirubin (TBIL) were examined by enzyme‐linked immunosorbent assay (ELISA) analysis. Hematoxylin and eosin (H&E) staining and Masson trichrome staining were used to determine liver tissue lesions and liver fibrosis. Compared with TGF‐β group, PC‐DCN treatment could significantly reduce cell proliferation. Western blot analysis indicated that the expression of α‐SMA, COL1A1, and TGF‐β was downregulated after treatment with PC‐DCN in vitro and in vivo. Immunofluorescence staining confirmed that α‐SMA expression was reduced by PC‐DCN. Furthermore, H&E staining and Masson trichrome staining showed that the administration of PC‐DCN nanoliposomes via the bile duct could reduce the extent of liver fibrosis. PCR analysis showed that PC‐DCN administration could reduce proinflammatory cytokines IL‐6, TNF‐α, and IL‐1β expression via the bile duct. The administration of PC‐DCN nanoliposomes also significantly downregulated liver function indicators ALT, AST, and TBIL. The results of our study indicated that PC‐DCN could effectively reduce the extent of liver fibrosis.

9 July 2024 in Obesity Surgery
Verified
Journal Article
Open access
PDF file
WYWeihua Yu
Weihua Yu
JCJionghuang Chen
Jionghuang Chen
LFLuqi Fan
Luqi Fan
CYChenli Yan
Chenli Yan
LZLinghua Zhu
Linghua Zhu
Background: Laparoscopic sleeve gastrectomy (LSG) is the most popular bariatric surgery procedure in China. However, its cost-effectiveness in Chinese patients is currently unknown. Objectives: This study aims to assess the cost-effectiveness of LSG vs no surgery in Chinese patients with severe and complex obesity, taking into account both healthcare expenses and the potential improvement in health-related quality of life (HRQoL). Methods: A retrospective cohort study was conducted, encompassing 135 Chinese patients who underwent LSG between January 3, 2022 and December 29, 2022, at a major bariatric center. The study evaluated the cost-effectiveness from a healthcare service perspective, employing the incremental cost-effectiveness ratio (ICER) for quality-adjusted life years (QALYs) gained. The analyses compared LSG with the alternative of not undergoing surgery over a 1-year period, using actual data, and extended to a lifetime horizon by projecting costs and utilities at an annual discount rate of 3.0%. Subgroup analyses were undertaken to explore cost-effectiveness variations across different sex, age and BMI categories, and diabetes status, employing a one-way analysis of variance (ANOVA). To ensure the reliability of the findings, one-way and probabilistic sensitivity analyses were executed. Results: The results indicated that 1-year post-LSG, patients achieved an average total weight loss (TWL) of (32.7 ± 7.3)% and an excess weight loss (EWL) of (97.8 ± 23.1)%. The ICER for LSG compared to no surgery over a lifetime was $4,327/QALY, significantly below the willingness-to-pay (WTP) threshold for Chinese patients with severe and complex obesity. From a lifetime perspective, LSG proved to be cost-effective for all sex and age groups, across all BMI categories, and for both patients with and without diabetes. Notably, it was more cost-effective for younger patients, patients with higher BMI, and patients with diabetes. Conclusions: LSG is a highly cost-effective intervention for managing obesity in Chinese patients, delivering substantial benefits in terms of HRQoL improvement at a low cost. Its cost-effectiveness is particularly pronounced among younger individuals, those with higher BMI, and patients with diabetes. Graphical

12 August 2022 in Canadian Journal of Gastroenterology and Hepatology
Verified
Journal Article
Open access
PDF file
GCGuojun Chen
Guojun Chen
WLWenhuan Li
Wenhuan Li
WYWeihua Yu
Weihua Yu
DCDong Cen
Dong Cen
XWXianfa Wang
Xianfa Wang
LZLinghua Zhu
Linghua Zhu
Delta-shaped gastroduodenostomy (DSGD) and overlap gastroduodenostomy (OGD) are the two most widely used intracorporeal Billroth I anastomosis methods after distal gastrectomy. In this study, we compared the short-term outcomes of DSGD and OGD in total laparoscopic distal gastrectomy (TLDG). In a retrospective cohort study, we examined 92 gastric cancer patients who underwent TLDG performed by the same surgeon between January 2014 and June 2018. All patients underwent Billroth I reconstruction (OGD, n = 45; DSGD, n = 47) and D2 lymph node dissection. We retrospectively reviewed the surgical outcomes, clinical pathological results, and endoscopy results. Laparoscopic surgery was successfully performed in both groups without conversion to open surgery. The demographic and clinical characteristics were similar between the two groups ( ). There were no significant differences between the two groups in operation time (158.9 ± 13.6 min vs. 158.8 ± 14.8 min, ), anastomotic time (19.4 ± 3.0 min vs. 18.8 ± 2.9 min, ), intraoperative blood loss (88.9 ± 25.4 mL vs. 83.7 ± 24.3 mL, ), number of lymph node dissections (31.0 ± 7.1 vs. 29.2 ± 7.5, ), length of hospital stay (8.8 ± 2.7 days vs. 9.1 ± 3.0 days, ), fluid intake time (3.1 ± 0.7 days vs. 3.2 ± 0.7 days, ), and morbidity of postoperative complications (6.7% [3/45] vs. 10.6% [5/47], ). Endoscopy performed 6 months postoperatively showed that the residual food ( ), gastritis ( ), and bile ( ) classification score significantly decreased in the OGD group, and there were no significant differences 12 months postoperatively. OGD is a safe and effective reconstruction technique with comparable postoperative surgical outcomes and endoscopy results when compared with those of DSGD.